Research ArticleImmunometabolism

Induction of metabolic quiescence defines the transitional to follicular B cell switch

See allHide authors and affiliations

Science Signaling  22 Oct 2019:
Vol. 12, Issue 604, eaaw5573
DOI: 10.1126/scisignal.aaw5573

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

AMPing up B cell maturation

Glycolysis provides an important energy source during B cell activation. In contrast, Farmer et al. found that metabolic quiescence was important for the development of human follicular B cells from transitional B cell precursors. In comparison to transitional B cells, mouse and human follicular B cells had reduced expression of genes involved in aerobic respiration, increased AMPK activation, and greater amounts of the cell surface ectoenzymes CD39 and CD73, which generate extracellular adenosine. Transitional human B cells that expressed CD73 or were treated with an AMPK agonist preferentially acquired a follicular B cell phenotype. These data identify a previously uncharacterized metabolic checkpoint in B cell development.

Abstract

Transitional B cells must actively undergo selection for self-tolerance before maturing into their resting follicular B cell successors. We found that metabolic quiescence was acquired at the follicular B cell stage in both humans and mice. In follicular B cells, the expression of genes involved in ribosome biogenesis, aerobic respiration, and mammalian target of rapamycin complex 1 (mTORC1) signaling was reduced when compared to that in transitional B cells. Functional metabolism studies, profiling of whole-cell metabolites, and analysis of cell surface proteins in human B cells suggested that this transition was also associated with increased extracellular adenosine salvage. Follicular B cells increased the abundance of the cell surface ectonucleotidase CD73, which coincided with adenosine 5′-monophosphate–activated protein kinase (AMPK) activation. Differentiation to the follicular B cell stage in vitro correlated with surface acquisition of CD73 on human transitional B cells and was augmented with the AMPK agonist, AICAR. Last, individuals with gain-of-function PIK3CD (PI3Kδ) mutations and increased pS6 activation exhibited a near absence of circulating follicular B cells. Together, our data suggest that mTORC1 attenuation may be necessary for human follicular B cell development. These data identify a distinct metabolic switch during human B cell development at the transitional to follicular stages, which is characterized by an induction of extracellular adenosine salvage, AMPK activation, and the acquisition of metabolic quiescence.

View Full Text

Stay Connected to Science Signaling